Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 12
408
Views
5
CrossRef citations to date
0
Altmetric
Molecular Toxicology

MicroRNA-mediated calcineurin signaling activation induces CCL2, CCL3, CCL5, IL8, and chemotactic activities in 4,4′-methylene diphenyl diisocyanate exposed macrophages

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1436-1452 | Received 07 Sep 2021, Accepted 06 Nov 2021, Published online: 02 Dec 2021

References

  • Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. 1994. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest. 105(3):687–696.
  • Agarwal V, Bell GW, Nam J-W, Bartel DP. 2015. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 4:e05005.
  • Allport DC, Gilbert DS, Outterside SM. 2003. MDI and TDI: a safety, health and the environment: a source book and practical guide. New York (NY): J. Wiley.
  • Badewa AP, Hudson CE, Heiman AS. 2002. Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Exp Biol Med. 227(8):645–651.
  • Balhara J, Gounni AS. 2012. The alveolar macrophages in asthma: a double-edged sword. Mucosal Immunol. 5(6):605–609.
  • Barnes PJ. 2008. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 8(3):183–192.
  • Barthel R, Tsytsykova AV, Barczak AK, Tsai EY, Dascher CC, Brenner MB, Goldfeld AE. 2003. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol. 23(2):526–533.
  • Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, Jeffery PK, Durham SR, Kay AB. 1992. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 89(4):821–829.
  • Berges C, Naujokat C, Tinapp S, Wieczorek H, Hoh A, Sadeghi M, Opelz G, Daniel V. 2005. A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun. 333(3):896–907.
  • Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, Bernstein IL. 1993. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol. 92(3):387–396.
  • Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA. 2019. Immunologic mechanisms in asthma. Semin Immunol. 46:101333.
  • Busch R, Murti K, Liu J, Patra AK, Muhammad K, Knobeloch KP, Lichtinger M, Bonifer C, Wortge S, Waisman A, et al. 2016. NFATc1 releases BCL6-dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice. Eur J Immunol. 46(3):634–646.
  • Cantin AM, North SL, Hubbard RC, Crystal RG. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol. 63(1):152–157.
  • Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NA. 2019. Targeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 25(1):121–127.
  • Draijer C, Peters-Golden M. 2017. Alveolar macrophages in allergic asthma: the forgotten cell awakes. Curr Allergy Asthma Rep. 17(2):12.
  • Engfeldt M, Isaksson M, Zimerson E, Bruze M. 2013. Several cases of work-related allergic contact dermatitis caused by isocyanates at a company manufacturing heat exchangers. Contact Dermatitis. 68(3):175–180.
  • Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. 2003. MicroRNA targets in Drosophila. Genome Biol. 5(1):R1.
  • Fabbri LM, Boschetto P, Zocca E, Milani G, Pivirotto F, Plebani M, Burlina A, Licata B, Mapp CE. 1987. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis. 136(1):36–42.
  • Falvo JV, Tsytsykova AV, Goldfeld AE. 2010. Transcriptional control of the TNF gene. Curr Dir Autoimmun. 11:27–60.
  • Falvo JV, Uglialoro AM, Brinkman BM, Merika M, Parekh BS, Tsai EY, King HC, Morielli AD, Peralta EG, Maniatis T, et al. 2000. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol. 20(6):2239–2247.
  • Fischkoff SA. 1988. Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. Leuk Res. 12(8):679–686.
  • Fric J, Zelante T, Wong AY, Mertes A, Yu HB, Ricciardi-Castagnoli P. 2012. NFAT control of innate immunity. Blood. 120(7):1380–1389.
  • Fricker M, Gibson PG. 2017. Macrophage dysfunction in the pathogenesis and treatment of asthma. Eur Respir J. 50(3):1700196.
  • Gildea JJ, Harding MA, Gulding KM, Theodorescu D. 2000. Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement. Biotechniques. 29(1):81–86.
  • Goldfeld AE, McCaffrey PG, Strominger JL, Rao A. 1993. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med. 178(4):1365–1379.
  • Goldfeld AE, Strominger JL, Doyle C. 1991. Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med. 174(1):73–81.
  • Goleva E, Hauk PJ, Hall CF, Liu AH, Riches DW, Martin RJ, Leung DY. 2008. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol. 122(3):550–559.e553.
  • Gosset P, Tsicopoulos A, Wallaert B, Vannimenus C, Joseph M, Tonnel AB, Capron A. 1991. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol. 88(4):561–571.
  • Hamilton RF, Jr., Thakur SA, Holian A. 2008. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med. 44(7):1246–1258.
  • Heron M, Grutters JC, ten Dam-Molenkamp KM, Hijdra D, van Heugten-Roeling A, Claessen AM, Ruven HJ, van den Bosch JM, van Velzen-Blad H. 2012. Bronchoalveolar lavage cell pattern from healthy human lung. Clin Exp Immunol. 167(3):523–531.
  • Hettick JM, Law BF, Lin C-C, Wisnewski AV, Siegel PD. 2018. Mass spectrometry-based analysis of murine bronchoalveolar lavage fluid following respiratory exposure to 4,4'-methylene diphenyl diisocyanate aerosol. Xenobiotica. 48(6):626–636.
  • Hiraiwa K, van Eeden SF. 2013. Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants. Mediators Inflamm. 2013:619523.
  • Holgate ST. 2008. Pathogenesis of asthma. Clin Exp Allergy. 38(6):872–897.
  • Hoshi H, Ohno I, Honma M, Tanno Y, Yamauchi K, Tamura G, Shirato K. 1995. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy. 25(8):720–728.
  • Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, Tang Y, Chen YG, Jin CN, Yu Y, et al. 2020. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 48(D1):D148–D154.
  • Huffman LJ, Judy DJ, Frazer D, Shapiro RE, Castranova V, Billie M, Dedhia HV. 1997. Inhalation of toluene diisocyanate is associated with increased production of nitric oxide by rat bronchoalveolar lavage cells. Toxicol Appl Pharmacol. 145(1):61–67.
  • Hur GY, Sheen SS, Kang YM, Koh DH, Park HJ, Ye YM, Yim HE, Kim KS, Park HS. 2008. Histamine release and inflammatory cell infiltration in airway Mucosa in methylene diphenyl diisocyanate (MDI)-induced occupational asthma. J Clin Immunol. 28(5):571–580.
  • Jan RL, Chen SH, Chang HY, Yeh HJ, Shieh CC, Wang JY. 2008. Asthma-like syndrome in school children after accidental exposure to xylene and methylene diphenyl diisocyanate. J Microbiol Immunol Infect. 41(4):337–341.
  • Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, Vlachos IS, Tastsoglou S, Kanellos I, Papadimitriou D, Kavakiotis I, Maniou S, Skoufos G, et al. 2018. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 46(D1):D239–D245.
  • Kawano T, Matsuse H, Kondo Y, Machida I, Saeki S, Tomari S, Mitsuta K, Fukushima C, Obase Y, Shimoda T, et al. 2004. Tacrolimus reduces urinary excretion of leukotriene E(4) and inhibits aspirin-induced asthma to threshold dose of aspirin. J Allergy Clin Immunol. 114(6):1278–1281.
  • Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. 2007. The role of site accessibility in microRNA target recognition. Nat Genet. 39(10):1278–1284.
  • Kim RY, Pinkerton JW, Essilfie AT, Robertson AAB, Baines KJ, Brown AC, Mayall JR, Ali MK, Starkey MR, Hansbro NG, et al. 2017. Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma. Am J Respir Crit Care Med. 196(3):283–297.
  • Kramer B, Meichle A, Hensel G, Charnay P, Kronke M. 1994. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim Biophys Acta. 1219(2):413–421.
  • Kramer B, Wiegmann K, Kronke M. 1995. Regulation of the human TNF promoter by the transcription factor ETS. J Biol Chem. 270(12):6577–6583.
  • Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. 2005. Combinatorial microRNA target predictions. Nat Genet. 37(5):495–500.
  • Lawrence MC, Naziruddin B, Levy MF, Jackson A, McGlynn K. 2011. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. J Biol Chem. 286(2):1025–1036.
  • Liang J, Zhao H, Yao L, Tang H, Dong H, Wu Y, Liu L, Zou F, Cai S. 2015. Phosphatidylinositol 3-kinases pathway mediates lung caspase-1 activation and high mobility group box 1 production in a toluene-diisocyanate induced murine asthma model. Toxicol Lett. 236(1):25–33.
  • Lin CC, Law BF, Hettick JM. 2020. Acute 4,4′-methylene diphenyl diisocyanate exposure-mediated downregulation of miR-206-3p and miR-381-3p activates inducible nitric oxide synthase transcription by targeting calcineurin/NFAT signaling in macrophages. Toxicol Sci. 173(1):100–113.
  • Lin CC, Law BF, Siegel PD, Hettick JM. 2019. Circulating miRs-183-5p, -206-3p and -381-3p may serve as novel biomarkers for 4,4′-methylene diphenyl diisocyanate exposure. Biomarkers. 24(1):76–90.
  • Lin CC, Liu LZ, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM. 2011. A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Mol Cell Biol. 31(12):2513–2527.
  • Lock SH, Kay AB, Barnes NC. 1996. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med. 153(2):509–514.
  • Lofgren DJ, Walley TL, Peters PM, Weis ML. 2003. MDI exposure for spray-on truck bed lining. Appl Occup Environ Hyg. 18(10):772–779.
  • Lu TP, Lee CY, Tsai MH, Chiu YC, Hsiao CK, Lai LC, Chuang EY. 2012. miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PLOS One. 7(8):e42390.
  • Maldonado-Perez D, Brown P, Morgan K, Millar RP, Thompson EA, Jabbour HN. 2009. Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway. Biochim Biophys Acta. 1793(7):1315–1324.
  • Matheson JM, Johnson VJ, Vallyathan V, Luster MI. 2005. Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma. Toxicol Sci. 84(1):88–98.
  • Matheson JM, Lemus R, Lange RW, Karol MH, Luster MI. 2002. Role of tumor necrosis factor in toluene diisocyanate asthma. Am J Respir Cell Mol Biol. 27(4):396–405.
  • McCaffrey PG, Goldfeld AE, Rao A. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. J Biol Chem. 269(48):30445–30450.
  • Medoff BD, Thomas SY, Luster AD. 2008. T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol. 26:205–232.
  • Millius A, Weiner OD. 2010. Manipulation of neutrophil-like HL-60 cells for the study of directed cell migration. In: Papkovsky DB, editor. Live cell imaging: methods and protocols. Totowa (NJ): Humana Press; p. 147–158.
  • Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. 2006. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 126(6):1203–1217.
  • Monteseirín J. 2009. Neutrophils and asthma. J Investig Allergol Clin Immunol. 19(5):340–354.
  • Munn SA, Aschberger K, Cosgrove O, Pakalin S, PayaPerez A, Pellegrini G, Schwarz-Schulz B, Vegro S. 2005. European Union Risk Assessment Report: methylenediphenyl diisocyanate (MDI). Luxembourg: European Commission, Office for Official Publications of the European Communities.
  • Norzila MZ, Fakes K, Henry RL, Simpson J, Gibson PG. 2000. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med. 161(3):769–774.
  • Park H, Jung K, Kim H, Nahm D, Kang K. 1999. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy. 29(10):1395–1401.
  • Park YJ, Yoo SA, Kim M, Kim WU. 2020. The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases. Front Immunol. 11:195.
  • Pauluhn J, Woolhiser MR, Bloemen L. 2005. Repeated inhalation challenge with diphenylmethane-4,4′-diisocyanate in brown Norway rats leads to a time-related increase of neutrophils in bronchoalveolar lavage after topical induction. Inhal Toxicol. 17(2):67–78.
  • Pollaris L, Devos F, De Vooght V, Seys S, Nemery B, Hoet PH, Vanoirbeek JA. 2016. Toluene diisocyanate and methylene diphenyl diisocyanate: asthmatic response and cross-reactivity in a mouse model. Arch Toxicol. 90(7):1709–1717.
  • Radermecker C, Louis R, Bureau F, Marichal T. 2018. Role of neutrophils in allergic asthma. Curr Opin Immunol. 54:28–34.
  • Redlich CA, Homer RJ, Smith BR, Wirth JA, Cullen MR. 1996. Immunologic responses to isocyanates in sensitized asthmatic subjects. Chest. 109(3 Suppl):6S–8S.
  • Redlich CA, Karol MH. 2002. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol. 2(2–3):213–224.
  • Sales KJ, Maldonado-Perez D, Grant V, Catalano RD, Wilson MR, Brown P, Williams AR, Anderson RA, Thompson EA, Jabbour HN. 2009. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. Biochim Biophys Acta. 1793(12):1917–1928.
  • Sokolowska M, Rovati GE, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, Sava F, Angelina A, Palomares O, Akdis CA, et al. 2021. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I. Allergy. 76(1):114–130.
  • Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, Li D, Zhang G, Huang B, Feng ZH. 2008. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol. 181(9):6117–6124.
  • Statista. 2021. Methylene diphenyl diisocyanate demand worldwide from 2011 to 2020 with a forecast for 2022; [accessed 2021 Nov 16]. https://www.statista.com/statistics/750809/mdi-demand-worldwide/.
  • Staruch MJ, Camacho R, Dumont FJ. 1998. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells. Cell Immunol. 190(2):121–131.
  • Taniguchi H, Tokui K, Iwata Y, Abo H, Izumi S. 2011. A case of severe bronchial asthma controlled with tacrolimus. J Allergy. 2011:479129.
  • Tarkowski M, Vanoirbeek JA, Vanhooren HM, De Vooght V, Mercier CM, Ceuppens J, Nemery B, Hoet PH. 2007. Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am J Physiol Lung Cell Mol Physiol. 292(1):L207–L214.
  • Tiffany HL, Li F, Rosenberg HF. 1995. Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells. J Leukoc Biol. 58(1):49–54.
  • Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol. 20(16):6084–6094.
  • Tsai EY, Yie J, Thanos D, Goldfeld AE. 1996. Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol. 16(10):5232–5244.
  • Tsytsykova AV, Goldfeld AE. 2002. Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol Cell Biol. 22(8):2620–2631.
  • Vaeth M, Feske S. 2018. NFAT control of immune function: new frontiers for an abiding trooper. F1000Res. 7:260.
  • van der Veen TA, de Groot LES, Melgert BN. 2020. The different faces of the macrophage in asthma. Curr Opin Pulm Med. 26(1):62–68.
  • Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, Hoet PH. 2004. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci. 80(2):310–321.
  • Wisnewski AV, Liu J, Colangelo CM. 2015. Glutathione reaction products with a chemical allergen, methylene-diphenyl diisocyanate, stimulate alternative macrophage activation and eosinophilic airway inflammation. Chem Res Toxicol. 28(4):729–737.
  • Wisnewski AV, Liu J, Nassar AF. 2019. LC-UV-MS and MS/MS characterize glutathione reactivity with different isomers (2,2′ and 2,4′ vs. 4,4′) of methylene diphenyl-diisocyanate. EC Pharmacol Toxicol. 7(3):205–219.
  • Wisnewski AV, Liu J, Redlich CA. 2013. Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure. Chem Biol Interact. 205(1):38–45.
  • Wisnewski AV, Liu J, Redlich CA. 2020. Analysis of lung gene expression reveals a role for Cl− channels in diisocyanate-induced airway eosinophilia in a mouse model of asthma pathology. Am J Respir Cell Mol Biol. 63(1):25–35.
  • Wisnewski AV, Liu J. 2016. Immunochemical detection of the occupational allergen, methylene diphenyl diisocyanate (MDI), in situ. J Immunol Methods. 429:60–65.
  • Zhu X, Cui J, Yi L, Qin J, Tulake W, Teng F, Tang W, Wei Y, Dong J. 2020. The role of T cells and macrophages in asthma pathogenesis: a new perspective on mutual crosstalk. Mediators Inflamm. 2020:7835284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.